about
Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammationEvaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic feverPreclinical deposition of pathological prion protein in muscle of experimentally infected primatesUpregulation of Shiga toxin receptor CD77/Gb3 and interleukin-1β expression in the brain of EHEC patients with hemolytic uremic syndrome and neurologic symptoms.Understanding the natural variability of prion diseases.Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever.Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice.Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.Secretory pathway retention of mutant prion protein induces p38-MAPK activation and lethal disease in mice.Generation of monoclonal antibodies against prion proteins with an unconventional nucleic acid-based immunization strategy.BSE-associated prion-amyloid cardiomyopathy in primates.Shedding light on prion disease.No obvious phenotypic abnormalities in mice lacking the Pate4 gene.Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.Analysis of fibrosis in control or pressure overloaded rat hearts after mechanical unloading by heterotopic heart transplantationComplement 3-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microgliaComparative pathogenesis of Ebola virus and Reston virus infection in humanized mice
P50
Q27321143-E3EE7466-33BE-4AF9-A07A-6964A4E0FBFAQ27457152-1C6BC6C8-3F42-4C7B-9702-B2D1E6EFA83AQ28476111-7BA8804A-D857-4736-B882-9AC6CC4F6025Q33416244-D0951A5E-81CE-480C-813C-0A3030FC3700Q34613223-95249AD7-401C-46C5-898B-B9A54A157217Q36020913-A5CDBCDD-C3F9-4181-9339-BCA559600909Q38808517-8795B9DC-01A1-4BD2-8D41-46F01783181BQ39717594-2F879A85-A97D-4B81-83FF-44518642D64BQ40564182-08E366CB-8B05-4B3F-85AF-32E38CAA3015Q40687403-F35A8BFF-D4D8-4793-9A46-A20EE20660BAQ40929052-DC51E68B-633B-4E47-9B60-32ABAA1229E2Q42076335-F53B3421-3666-4BEB-B59C-FA7DA32924E7Q43226637-6FD02D6E-C146-4902-BDBC-4CA23F2AC18CQ50945585-FED5C5D9-E3C6-4F26-AC58-1AF8B37E0586Q55115778-F711AE49-4EA6-418A-94E4-F183FA354A94Q64074305-0AA160CE-96E7-4273-BE80-535D16EDDB59Q64275935-6BFE00CC-3DEF-47AB-ABA8-D4C299908A9BQ90255324-316CC602-7B50-4107-B3E3-BC858F28625E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Susanne Krasemann
@ast
Susanne Krasemann
@en
Susanne Krasemann
@es
Susanne Krasemann
@nl
Susanne Krasemann
@sl
type
label
Susanne Krasemann
@ast
Susanne Krasemann
@en
Susanne Krasemann
@es
Susanne Krasemann
@nl
Susanne Krasemann
@sl
prefLabel
Susanne Krasemann
@ast
Susanne Krasemann
@en
Susanne Krasemann
@es
Susanne Krasemann
@nl
Susanne Krasemann
@sl
P106
P21
P31
P496
0000-0001-8795-818X